Tumor necrosis factor-inhibitor treatment duration is associated with lower risk of hand osteoarthritis progression in patients with recent-onset rheumatoid arthritis after 10-year follow-up
Loef, M., Kroon, F.P., Bergstra, S.A., van der Pol, J.A., Lems, W.F., Kerstens, P.J., Allaart, C.F., Kloppenburg, M.Том:
26
Мова:
english
Журнал:
Osteoarthritis and Cartilage
DOI:
10.1016/j.joca.2018.02.604
Date:
April, 2018
Файл:
PDF, 226 KB
english, 2018
File converter
Більше результатів пошуку
More benefits 
